Bacterial, Viral & Fungal Infections Conditions (16)
Respiratory infections, shingles/HSV, pneumonia, skin infections, Lyme disease, HIV, and antimicrobial therapy.
40 Master Condition Specialty Hubs
Show All 40 Hubs ×Bacterial, Viral & Fungal Infections Guides (16)
Clear All Filters ×Ocular histoplasmosis
Cataloged under federal diagnostic code B39.9 in Infections & Antivirals, Ocular histoplasmosis (also termed Eyes or Vision) requires antimicrobial stewardship (narrow-spectrum in Ocular histoplasmosis (B39.9: pathogen-directed duration) or) so specialists can calibrate treatment intensity against Complete Blood Count in Ocular histoplasmosis (B39.9: (WBC & Differential)) benchmarks.
Onchocerciasis
Under Bacterial, Viral & Fungal Infections diagnostic criteria (B73.1), workup for Onchocerciasis integrates antimicrobial stewardship (narrow-spectrum in Onchocerciasis (B73.1: pathogen-directed duration) or) with evidence-graded therapy tailored to C-Reactive Protein / in Onchocerciasis (B73.1: Procalcitonin) response.
Onychomycosis
Onychomycosis—coded clinically as B35.1 across Infections & Antivirals guidelines—combines bacterial/fungal culture with in Onychomycosis (B35.1: antimicrobial susceptibility testing) with structured follow-up of C-Reactive Protein / in Onychomycosis (B35.1: Procalcitonin) (Resolution to baseline (B35.1)).
Orbital cellulitis
Physicians managing Orbital cellulitis (also termed Orbits or Orbital) (H05.019; Bacterial, Viral & Fungal Infections) utilize antimicrobial stewardship (narrow-spectrum in Orbital cellulitis (H05.019: pathogen-directed duration) or) and objective C-Reactive Protein / in Orbital cellulitis (H05.019: Procalcitonin) targets (Resolution to baseline (H05.019)) to prevent progression and functional morbidity.
Osteomyelitis - tuberculosis
Physicians managing Osteomyelitis - tuberculosis (also termed Miliary or Seeded) (A18.03; Bacterial, Viral & Fungal Infections) utilize antimicrobial stewardship (narrow-spectrum in Osteomyelitis - tuberculosis (A18.03: pathogen-directed duration) or) and objective C-Reactive Protein / in Osteomyelitis - tuberculosis (A18.03: Procalcitonin) targets (Resolution to baseline (A18.03)) to prevent progression and functional morbidity.
Other bacterial infections of unspecified site
Clinical triage of Other bacterial infections of unspecified site (A49.8) in Infections & Antivirals relies on bacterial/fungal culture with in Other bacterial infections of unspecified site (A49.8: antimicrobial susceptibility testing), guiding step-wise therapeutic adjustments toward C-Reactive Protein / in Other bacterial infections of unspecified site (A49.8: Procalcitonin) (Resolution to baseline (A49.8)).
Other dermatophytoses
Under Bacterial, Viral & Fungal Infections diagnostic criteria (B35.8), workup for Other dermatophytoses integrates sepsis/severity red-flag triage [Other dermatophytoses B35.8] with evidence-graded therapy tailored to Complete Blood Count in Other dermatophytoses (B35.8: (WBC & Differential)) response.
Other herpes zoster eye disease
Recognized across U.S. clinical coding as B02.39 (Infections & Antivirals), Other herpes zoster eye disease is evaluated via antimicrobial stewardship (narrow-spectrum in Other herpes zoster eye disease (B02.39: pathogen-directed duration) or) to align day-to-day symptom relief with long-term physiological stability.
Other herpesviral disease of eye
Cataloged under federal diagnostic code B00.59 in Infections & Antivirals, Other herpesviral disease of eye requires rapid antigen/NAAT PCR in Other herpesviral disease of eye (B00.59: diagnostics) so specialists can calibrate treatment intensity against Complete Blood Count in Other herpesviral disease of eye (B00.59: (WBC & Differential)) benchmarks.
Other herpesviral infection
Clinical triage of Other herpesviral infection (B00.89) in Infections & Antivirals relies on antimicrobial stewardship (narrow-spectrum in Other herpesviral infection (B00.89: pathogen-directed duration) or), guiding step-wise therapeutic adjustments toward C-Reactive Protein / in Other herpesviral infection (B00.89: Procalcitonin) (Resolution to baseline (B00.89)).
Other pneumonia, unspecified organism
Clinical triage of Other pneumonia, unspecified organism (J18.8) in Infections & Antivirals relies on antimicrobial stewardship (narrow-spectrum in Other pneumonia, unspecified organism (J18.8: pathogen-directed duration) or), guiding step-wise therapeutic adjustments toward C-Reactive Protein / in Other pneumonia, unspecified organism (J18.8: Procalcitonin) (Resolution to baseline (J18.8)).
Other postherpetic nervous system involvement
Under Bacterial, Viral & Fungal Infections diagnostic criteria (B02.29), workup for Other postherpetic nervous system involvement integrates antimicrobial stewardship (narrow-spectrum in Other postherpetic nervous system involvement (B02.29: pathogen-directed duration) or) with evidence-graded therapy tailored to C-Reactive Protein / in Other postherpetic nervous system involvement (B02.29: Procalcitonin) response.
Other sites of candidiasis
Designated in federal medical registries as B37.89, Other sites of candidiasis falls under Infections & Antivirals management, where antimicrobial stewardship (narrow-spectrum in Other sites of candidiasis (B37.89: pathogen-directed duration) or) establishes baseline severity and rules out diagnostic mimics.
Other urogenital candidiasis
Cataloged under federal diagnostic code B37.49 in Infections & Antivirals, Other urogenital candidiasis requires sepsis/severity red-flag triage [Other urogenital candidiasis B37.49] so specialists can calibrate treatment intensity against C-Reactive Protein / in Other urogenital candidiasis (B37.49: Procalcitonin) benchmarks.
Otomycosis
For patients presenting with Otomycosis (ICD-10-CM B36.9), Bacterial, Viral & Fungal Infections protocols prioritize antimicrobial stewardship (narrow-spectrum in Otomycosis (B36.9: pathogen-directed duration) or) paired with baseline and interval Targeted PCR / in Otomycosis (B36.9: Culture & Sensitivity) assessment.
Otosyphilis
Within Bacterial, Viral & Fungal Infections practice, Otosyphilis (ICD-10 A52.15) is stratified through antimicrobial stewardship (narrow-spectrum in Otosyphilis (A52.15: pathogen-directed duration) or), pairing targeted symptom control with longitudinal Targeted PCR / in Otosyphilis (A52.15: Culture & Sensitivity) surveillance.